Freedom to operate analysis: when you need one and what it involves

A freedom to operate analysis asks one question: can you make, use, sell or import a specific product or process in a specific country without infringing someone else’s in-force patent? It is not about whether your own invention is new. It is about whether other people’s claims read on what you are about to ship.

This article is for founders and technical leads at deep-tech companies heading into a launch, a financing or a partnership. It covers how FTO differs from patentability, when it is worth doing, what it examines, what to do with the results, and why willful infringement law matters.

Key takeaways

• A freedom to operate (FTO) analysis looks at other people’s patent claims, not at your own invention’s novelty. Owning a patent does not give you the right to practice your invention.
• Scope is set by three things: the exact product or process, the countries where you will make or sell it, and the in-force patents and pending applications in those countries.
• The best times to do one are before a commercial launch, before you lock in a design, and before a fundraise, partnership or acquisition where someone will ask about it.
• A problem patent usually has an answer: design around it, license it, challenge its validity, or wait for it to expire.
• Since Halo v. Pulse, enhanced damages turn on what you knew and did at the time. Under 35 U.S.C. § 298, not getting an opinion of counsel cannot be used to prove willfulness.

What is a freedom to operate analysis?

A freedom to operate analysis is a review of in-force patents and pending applications in the countries where you plan to do business, to judge whether your product or process would infringe any of their claims. The output is a risk assessment for a defined product in defined markets. It is a snapshot in time, not a permanent clearance.

The legal hook is the infringement statute. Under 35 U.S.C. § 271(a), anyone who without authority makes, uses, offers to sell, sells or imports a patented invention in the United States during the patent term infringes. “Patented invention” means what the claims say. Claims are the numbered sentences at the end of a patent that define the legal boundary of the right, so an FTO turns on claim language, not titles or abstracts.

Patentability vs. freedom to operate

Founders often assume that if they have a patent, or a patentable invention, they are free to sell it. They are not. A patent gives the right to exclude others. It gives no right to practice, because your improvement can sit inside someone else’s broader claim.

Here is a concrete case. Say you have patented a new cladding geometry for a silicon nitride waveguide. A competitor holds a patent claiming “a photonic integrated circuit comprising a silicon nitride waveguide and a thermo-optic phase shifter.” If your chip has both, you may infringe their claim even though your geometry is new. The word “comprising” is open-ended: adding features does not get you out. I go into how claims like this are drafted in how to claim a photonic integrated circuit.

When do you need a freedom to operate analysis?

You need a freedom to operate analysis when the cost of finding a blocking patent later would be much higher than finding it now. In practice that means before a commercial launch, before a design freeze, and before a financing, partnership or acquisition where the other side will ask about patent risk.

The most common triggers I see:

• Before launch or design freeze. A crystalline form, a dopant concentration or a pulse sequence is easy to change on a whiteboard and expensive to change after validation.
• Before a fundraise. Diligence questions about third-party patents are common, and a focused FTO on your lead product is a stronger answer than “we haven’t seen anything.” I cover how these conversations usually go in what investors ask about your patents.
• Before a partnership or license. Knowing your risk map lets you negotiate indemnities and royalty terms from facts.
• Before an acquisition. On either side of the table, FTO findings feed into price, representations and warranties, and indemnities.

One nuance for drug developers: § 271(e)(1) exempts activity solely for uses reasonably related to developing and submitting information under a federal law regulating drugs or veterinary biological products. That safe harbor is narrow. It does not cover commercial sales or serve as a general research exemption for other technologies.

What does an FTO analysis cover?

An FTO covers three things: a precise description of what you will make or sell, the countries where that will happen, and the in-force patents and pending applications in those countries whose claims might reach it.

The product or process, defined precisely

Claims are compared to a specific embodiment. “Our quantum control stack” is too vague. “Pulse-level calibration software that performs these five steps on customer hardware” is something a claim can be measured against.

Jurisdictions

Patents are territorial. As WIPO explains, exclusive rights apply only in the country or region where a patent was filed and granted, and there is no “world patent.” Importing into the United States is itself an infringing act under § 271(a), so your FTO should follow your supply chain: where you manufacture, sell and ship.

In-force patents, pending applications and expiry dates

Only patents that are in force can be infringed. Under 35 U.S.C. § 154(a)(2), a U.S. utility patent generally ends 20 years from its filing date, or from the filing date of the earliest U.S. or PCT application it claims continuity from, subject to adjustments. Claiming priority to a provisional application does not start that 20-year clock. It also lapses early if the owner fails to pay maintenance fees, which the USPTO collects at 3.5, 7.5 and 11.5 years after issue, with grace periods.

Pending applications matter too. Most U.S. applications publish about 18 months after their earliest priority date under 35 U.S.C. § 122(b), so there is always a window of unpublished filings no search can see. Once published, § 154(d) can give the owner a reasonable royalty for pre-grant use if you had actual notice of the application and the issued claims are substantially identical. Pending claims can also change, so a good FTO lists applications to watch.

How does the FTO process work?

A typical freedom to operate analysis moves from defining the product, to searching, to screening hits, to a detailed claim-by-claim comparison of the few patents that survive screening. The final step is a written assessment of risk and options.

1. Define the product and markets. List the features, materials, process steps and countries in scope, with your engineers in the room.
2. Search. Search patents and published applications by keyword, classification and assignee. The USPTO’s Patent Public Search covers U.S. documents; other offices’ databases cover the rest.
3. Screen. Read the independent claims of each hit and discard those that clearly require something your product lacks.
4. Construe the claims. Work out what each term means, using the specification and the prosecution history (what the applicant told the examiner to get the patent).
5. Compare element by element. Build a claim chart mapping each claim element to your product. Infringement generally requires every element, literally or by an equivalent.
6. Check status and validity. Confirm the patent is in force, find its expiry date, and note prior art that could invalidate it.
7. Assess and recommend. Rank the risks and pair each one with realistic options.

This is where scientific training earns its keep. Whether your compound falls inside a Markush claim (a claim listing alternative substituents at each position), or whether your qubit device “comprises a resonator coupled to” something, can turn on details the drafter never spelled out. Reading those claims well means understanding the chemistry or the device as deeply as the person who wrote them.

What can you do if the FTO finds a blocking patent?

A blocking patent is a decision point, not a dead end. The usual options are to design around the claims, take a license, challenge the patent’s validity, or wait for it to expire. The right choice depends on the strength of the claim, your timeline, the patent owner, and how central the claimed feature is to your product.

Two cautions on the first options. A design-around must remove a claim element; substituting something that performs substantially the same function in substantially the same way may still infringe under the doctrine of equivalents. Licenses, including from universities, can be narrow (one field, one territory) and are usually easier to negotiate before launch.

Invalidity and inter partes review

If good prior art exists, you can challenge the patent. Inter partes review (IPR) is a proceeding at the USPTO’s Patent Trial and Appeal Board in which a third party asks the Office to cancel claims as anticipated or obvious, based only on prior patents and printed publications. The USPTO’s IPR page sets out the basics, including the filing window that opens nine months after grant.

Be careful about relying on IPR as a plan. Institution is discretionary, and the USPTO’s approach has shifted substantially since 2025. In October 2025 the Office published a proposed rule that would, among other things, bar institution where claims were previously upheld or where a parallel court case is likely to finish first, and would require petitioners to give up certain invalidity arguments elsewhere. Check the current rules at the time you need them.

Wait for expiry

If a key patent expires before your launch, or has lapsed for unpaid maintenance fees, the risk may disappear on its own. Confirm the actual expiry date, including any term adjustment, and look for longer-lived family members. The same timing logic applies to your own filings; see when the patent clock starts.

Why does willful infringement matter for a freedom to operate analysis?

Willful infringement matters because U.S. courts can increase damages up to three times when infringement is egregious. Since Halo v. Pulse in 2016, that question turns on what the infringer knew and believed at the time. A careful FTO, and how you act on it, can be part of that record.

Under 35 U.S.C. § 284, a court “may increase the damages up to three times the amount found or assessed.” In Halo Electronics, Inc. v. Pulse Electronics, Inc., the Supreme Court rejected the Federal Circuit’s earlier two-part Seagate test. It held that enhanced damages should generally be reserved for egregious cases typified by willful misconduct, that culpability is generally measured against the actor’s knowledge at the time of the challenged conduct, and that a preponderance of the evidence standard applies.

Two points follow. First, 35 U.S.C. § 298 says that failing to obtain advice of counsel, or failing to present it in court, may not be used to prove willful infringement or intent to induce infringement. Second, once you know about a patent, what you do next matters. A reasoned analysis, prepared before the conduct and acted on in good faith, shows what you believed at the time.

Some companies avoid looking at patents so they cannot be said to know about them. That trades a legal risk for a business one: you may build a product around a blocking claim you could have found early. For most deep-tech companies, a targeted review of the patents that matter is the better trade. Keep it focused: your lead product, its hardest-to-change features, and the markets that drive revenue in the next few years. I do this work alongside portfolio building for startups and university spin-outs.

Frequently asked questions

Is a freedom to operate analysis the same as a patent search?

No. A search is one step. A freedom to operate analysis adds claim construction, an element-by-element comparison with your product, a check of each patent’s legal status and expiry, and a judgment about risk and options. A list of search hits without that analysis tells you little about whether you can actually launch.

If I have a patent, do I still need an FTO?

Often yes. A patent gives you the right to stop others from practicing your claims. It does not give you a right to practice them yourself. If your improvement falls within someone else’s broader, earlier claim, you can infringe their patent while holding a valid patent of your own.

How long is an FTO analysis valid?

It reflects the patents, applications and product as they were on the date of the analysis. New patents issue, pending claims change, and products evolve. Revisit it when your design changes, when you enter a new market, or when a relevant patent or application publishes, and at major milestones like a financing.

Do I need an FTO before talking to investors?

Not always before the first meeting. Early investors tend to ask about your own portfolio. Later-stage investors and corporate partners are more likely to ask about third-party patents during diligence. Having a focused analysis on your lead product ready by then makes those conversations shorter and more concrete.

Talk it through before you launch

If you are approaching a launch, a financing or a partnership and want to know which third-party patents actually matter for your product, I’m glad to help you scope a freedom to operate analysis that fits the decision in front of you.

This article is general information, not legal advice, and reading it does not create an attorney-client relationship. Patent law changes and every situation differs. Please talk to a patent attorney about yours.

Message Alexander on LinkedIn